|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pediatric functional constipation treatment with Bifi dobacterium-containing yogurt:A crossover,double-blind,controlled trial显示文摘AIM: To evaluate the treatment of pediatric functional chronic intestinal constipation (FCIC) with a probiotic goat yogurt. METHODS: A crossover double-blind formula-controlled trial was carried out on 59 students (age range: 5-15 years) of a public school in Belo Horizonte, MG, Brazil, presenting a FCIC diagnostic, according to Roma Ⅲ criteria. The students were randomized in two groups to receive a goat yogurt supplemented with 109 colony forming unit/mL Bifidobacterium longum (B.longum) (probiotic) daily or only the yogurt for a period of 5 wk (formula). Afterwards, the groups were intercrossed for another 5 wk. Defecation frequency, stool consistency and abdominal and defecation pain were assessed.RESULTS: Both treatment groups demonstrated improvement in defecation frequency compared to baseline. However, the group treated with probiotic showed most signif icant improvement in the f irst phase of the study. An inversion was observed after crossing over, resulting in a reduction in stool frequency when this group was treated by formula. Probiotic and formula improved stool consistency in the f irst phase of treatment, but the improvement obtained with probiotic was significantly higher (P = 0.03). In the second phase of treatment, the group initially treated with probiotic showed worseningstool consistency when using formula. However, the difference was not signif icant. A signif icant improvement in abdominal pain and defecation pain was observed with both probiotic and formula in the first phase of treatment, but again the improvement was more signif icant for the group treated with B. longum during phase I (P < 0.05). When all data of the crossover study were analyzed, significant differences were observed between probiotic yogurt and yogurt only for defecation frequency (P = 0.012), defecation pain (P = 0.046) and abdominal pain (P = 0.015). | Paula VP Guerra Luiza N Lima Tassia C Souza Vanessa Mazochi Francisco J Penna Andreia M Silva Jacques R Nicoli Elizabet V Guimares | 2011 | World Journal of Gastroenterology2011，17，34： | 25 |
| 2 | Deep sedation during gastrointestinal endoscopy: Propofol-fentanyl and midazolam-fentanyl regimens显示文摘AIM: To compare deep sedation with propofol-fentanyl and midazolam-fentanyl regimens during upper gastrointestinal endoscopy. METHODS: After obtaining approval of the research ethics committee and informed consent, 200 patients were evaluated and referred for upper gastrointestinal endoscopy. Patients were randomized to receive propofol-fentanyl or midazolam-fentanyl (n = 100/group).We assessed the level of sedation using the observer's assessment of alertness/sedation (OAA/S) score and bispectral index (BIS). We evaluated patient and physician satisfaction, as well as the recovery time and complication rates. The statistical analysis was performed using SPSS statistical software and included the MannWhitney test, χ 2 test, measurement of analysis of variance, and the κ statistic. RESULTS: The times to induction of sedation, recovery, and discharge were shorter in the propofolfentanyl group than the midazolam-fentanyl group. According to the OAA/S score, deep sedation events occurred in 25% of the propofol-fentanyl group and 11% of the midazolam-fentanyl group (P = 0.014). Additionally, deep sedation events occurred in 19% of the propofol-fentanyl group and 7% of the midazolamfentanyl group according to the BIS scale (P = 0.039). There was good concordance between the OAA/S score and BIS for both groups (κ = 0.71 and κ = 0.63, respectively). Oxygen supplementation was required in 42% of the propofol-fentanyl group and 26% of the midazolam-fentanyl group (P = 0.025). The mean time to recovery was 28.82 and 44.13 min in the propofolfentanyl and midazolam-fentanyl groups, respectively (P < 0.001). There were no severe complications in either group. Although patients were equally satisfied with both drug combinations, physicians were more satisfied with the propofol-fentanyl combination. CONCLUSION: Deep sedation occurred with propofolfentanyl and midazolam-fentanyl, but was more frequent in the former. Recovery was faster in the propofol-fentanyl group. | Marcos Eduardo Lera dos Santos Fauze Maluf-Filho Dalton Marques Chaves Sergio Eiji Matuguma Edson Ide Gustavo de Oliveira Luz Thiago Ferreira de Souza Fernanda C Simoes Pessorrusso Eduardo Guimares Hourneaux de Moura Paulo Sakai | 2013 | World Journal of Gastroenterology2013，19，22： | 16 |
| 3 | 螺内酯与可乐定作为难治性高血压第4种治疗药物的比较:难治性高血压的最佳治疗随机研究显示文摘该研究旨在通过一个多中心随机试验对作为难治性高血压患者的第4种治疗药物的螺内酯与可乐定进行比较。采用药丸计数评估药物治疗依从性。难治性高血压患者(定义为包括1种利尿剂在内的3种药物治疗12周,诊室及动态血压监测血压仍未控制)随机给予螺内酯(12.5~50 mg/d)或可乐定(0.1~0.3mg,2次/d)继续治疗12周。 | Krieger EM Drager LF Giorgi DMA Pereira AC Barreto-Filho JAS Nogueira AR Mill JG Lotufo PA Amodeo C Batista MC Bodanese LC Carvalho ACC Castro I Chaves H Costa EAS Feitosa GS Franco RJS Fuchs FD Guimarāes AC Jardim PC Machado CA Magalhāes ME Mion D Jr Nascimento RM Nobre F Nóbrega AC Ribeiro ALP Rodrigues-Sobrinho CR Sanjuliani AF Teixeira MDCB Krieger JE ReHOT Investigators 赵狄 练桂丽 | 2018 | 中华高血压杂志2018，26，3： | 7 |
| 4 | FeNb在钢液中的溶化行为及在钢包精炼过程中提高Nb收得率的最佳工艺显示文摘阐述了标准铌铁(FeNb)的微观组织特性及其溶入钢液中的研究结果。在实验室的感应炉中进行了不同温度下的非连续试验,分析了固相FeNb与钢液凝固层界面的微观组织,并与原始FeNb粒子的微观组织进行了对比。这些试验研究结果可以阐释FeNb的溶解机制和它在不同炼钢温度下的融入动力学条件。标准FeNb在钢水中溶解的试验结果证实FeNb颗粒的溶解速率高于有关文献中报告的结果,它们认为FeNb粒子的熔化温度高(>1600℃),所以在其模型中假定FeNb的溶解仅是通过固相粒子的扩散实现。本项工作得到的试验证据为标准FeNb的溶解机理提供了一种新的说法:在1500~1510℃受其共晶区的熔化行为控制,在1530~1575℃温度范围内则由初始板条相的熔化行为所主导,也就是说,均低于1600℃左右的炼钢温度。根据这些研究结果和炼钢厂已有的生产经验,对于微合金化钢在二次精炼阶段加入FeNb推荐了最优的工艺。 | Edmundo Burgos Cruz Daniel Pallos Fridman Marcelo C Carboni Rogério Contato Guimares Marcos A Stuart Nogueira Ferdinando Luiz Cavallante 王厚昕 | 2010 | 世界钢铁2010，，6： | 2 |
| 5 | Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells显示文摘 | Guimarǎes E L Empsen C Geerts A | | 0，，03： | 1 |
| 6 | A parametric study of forced convection in an enclosure with stationary heated cylinders显示文摘 | Guimar?es P M Da Silva C E S | 2010 | International Communications in Heat and Mass Transfer2010，37，5： | 1 |
| 7 | Use of Autologous Mesenchymal Stem Cells Derived from Bone Marrow for the Treatment of Naturally Injured Spinal Cord in Dogs显示文摘 | Euler Moraes Penha Cássio Santana Meira Elisalva Teixeira Guimar?es Marcus Vinícius Pinheiro Mendon?a Faye Alice Gravely Cláudia Maria Bahia Pinheiro Taiana Maria Bahia Pinheiro Stella Maria Barrouin-Melo Ricardo Ribeiro-dos-Santos Milena Botelho Pereira | 2014 | Stem Cells International2014，，： | 1 |
| 8 | 黄粉虫替代蛋白质饲料对太平洋白虾(凡纳滨对虾)消化性能的影响显示文摘试验旨在评估黄粉虫粉(MM)作为凡纳滨对虾养殖中蛋白质来源的可行性。饲料分为正常饲料和试验饲粮,试验饲料中包含正常饲料85%和MM 15%,两种饲料中均含有氧化铬0.5%作为惰性标记,试验采用表观消化率系数(ADC)对两种饲料进行检测。为评估MM消化价值,对虾饲料中采用鱼粉替代MM,替代比例分别为0%、25%、50%、75%和100%,在清水中饲养6周后,对生长参数和整个虾体成分进行评估。干物质ADC为45.9%,能量ADC为66.5%,粗蛋白质ADC为76.1%,必须氨基酸ADC为72%~86%。MM中蛋氨酸为第一限制性氨基酸。饲料中添加MM后,各组间对虾的体增重、特定生长率、采食量、饲料转化率、存活率和蛋白质合成率均无显著变化(P>0.05),虾体蛋白质含量无显著差异(P>0.05)。而随着鱼粉替代比例上升,虾体脂含量从1.13%升至1.88%。结果表明,黄粉虫粉可作为凡纳滨对虾饲料中的替代蛋白质饲料,但添加时应注意补充蛋氨酸。 | Panini R L Freitas L E L Guimarǎes A M Rios C da Silva M F O Vieira F N Fracalossi D M Samuels R I | 2017 | 饲料博览2017，0，7： | 1 |
| 9 | Polymerization stress,shrinkage and elastic modulus of current low-shrinkage re- storative composites显示文摘 | Boaro L C Gonalves F Guimares T C | 2004 | Dental Materials2004，20，10： | 1 |
| 10 | 131I effective half-life(Teff)for patients with thyroid cancer显示文摘 | WILLEGAIGNON J MALVESTITI L F GUIMAR(A)ES M I C | 2006 | Health Phys2006，91，： | 1 |
| 11 | Acute fibrinous and organising pneumonia显示文摘 | Guimar(a)es C Sanches I Ferreira C | | 0，，： | 1 |
| 12 | Focal dermal hypoplasia:a case report and literature review显示文摘 | Murakami C de Oliveira Lira Ortega A Guimar(a)es AS | 2011 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod2011，112，2： | 1 |
| 13 | Degradation kinetics of anthocyanin in blueberry juice during thermal treatment显示文摘 | Kechinski C P Guimar ES P V R Nore A C P Z | 2010 | Journal of Food Science2010，75，2： | 1 |
| 14 | Mercury fluxes in a natural forested Amazonian catchment (Serra do Navio,Amapà State,Brazil)显示文摘 | Fostier A H Forti M C Guimaràes J R D | 2000 | The Science of the Total Environment2000，26，： | 1 |
| 15 | A gene in the multidrug and toxic compound extrusion(MATE)family confers aluminum tolerance in sorghum显示文摘 | MAGALHAES J V LIU J GUIMARES C T | 2007 | Nature Genetics2007，39，9： | 1 |
| 16 | Cyclohexane hydroxylation by iodosylbenzene and iodobenzene diacetate catalyzed by a new 13-octahalogenated Mn-porphyrin complex: The effect of meso-3-pyridyl substituents显示文摘 | de Freitas Silva G Da Silva D C Guimares A S | 2007 | Journal ofMolecular Catalysis A: Chemical2007，266，1： | 1 |
| 17 | Two functionally distinct members of the MATE (multi-drug and toxic compound extrusion) family of transporters potentially underlie two major aluminum tolerance QTLs in maize 显示文摘 | Maron LG Pi?eros MA Guimar?es CT Magalhaes JV Pleiman JK Mao C Shaff J Belicuas SNJ Kochian LV | 2010 | Plant J2010，61，： | 1 |
| 18 | Selectivity in phosphate column flotation显示文摘 | Oliveira M S Queiroz G M Guimarāes R C | | 0，，： | 1 |
| 19 | Chemical restraint of peccaries with tiletamine/zolazepam and xylazine or tiletamine/zolazepam and butorphanol显示文摘 | Selmi A L Mendes G M Figueiredo J P Guimar(a)es F B Selmi G R Bernal F E McMannus C Paludo G R | | 0，，： | 1 |
| 20 | Advances in craniosynostosis research and management 显示文摘 | Guimar?es-Ferreira J Migue ns J Lauritzen C | 2004 | Adv Tech Stand Neurosurg2004，29，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员